Related Experiment Videos

Target intervention against multiple-risk markers to reduce cardiovascular disease in patients with type 2 diabetes

Peter Gaede1, Oluf Pedersen

  • 1Steno Diabetes Center, Niels Steensensvej 2, 2820 Gentofte, Copenhagen, Denmark.

Annals of Medicine
|October 14, 2004
PubMed

Insights

Patients with type 2 diabetes have double the risk of cardiovascular disease. Intensified multifactorial treatment significantly reduces cardiovascular events and mortality by 50%.

Area of Science:

  • Cardiology
  • Endocrinology
  • Public Health

Background:

  • Type 2 diabetes significantly elevates cardiovascular disease (CVD) risk, occurring twice as frequently as in the general population.
  • Recognizing shared risk factors for microvascular and macrovascular complications in type 2 diabetes has prompted evolving treatment strategies.

Purpose of the Study:

  • To review recent drug trials guiding effective multifactorial treatment for type 2 diabetes.
  • To highlight the impact of intensified interventions on cardiovascular risk in diabetic patients.

Main Methods:

  • Review of recent clinical trials focusing on multifactorial interventions for type 2 diabetes.
  • Analysis of data from the Steno-2 Study on intensive risk factor management.

Main Results:

  • The Steno-2 Study demonstrated a 50% reduction in a composite endpoint including cardiovascular mortality, myocardial infarction, stroke, and lower-limb amputations.
  • Intensified multifactorial intervention targeting multiple risk factors proved effective in reducing major adverse cardiovascular events.

Conclusions:

  • Multifactorial treatment strategies are crucial for managing cardiovascular risk in type 2 diabetes.
  • Intensified interventions, as shown by the Steno-2 Study, significantly improve outcomes for patients with type 2 diabetes and high cardiovascular risk.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Type II Diabetes I: Introduction01:26

Type II Diabetes I: Introduction

Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder characterized by insulin resistance, in which target tissues such as the liver, muscle, and adipose tissue respond poorly to insulin. It is also associated with inadequate compensatory insulin secretion, where pancreatic β-cells fail to produce sufficient insulin. Together, these abnormalities lead to persistent hyperglycemia.EtiologyT2DM develops through a complex interaction of genetic predisposition and environmental or...